INOC-002

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameINOC-002
Drug Alias NameBIO-117INOC-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action3',5'-cyclic phosphodiesterase inhibitors
Targets3',5'-cyclic phosphodiesterase
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAvantogen Oncology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAvantogen Oncology
Active IndicationsN/A
Inactive IndicationsColorectal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A